Experimental Gilead Sciences, Inc. Drug Effective in Early-Stage Leukemia Trial

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had ret…

---

Gilead Sciences, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the…

---

Gilead profits surge 63%, but not where Wall Street expected

Gilead Sciences was in a position to say, "I told you so," when its first-quarter earnings fell a little short of Wall Street expectations Thursday. Profits were still up 63% even as sales of older HI…

---

Gilead Sciences, Inc.’s HCV Drugs Shine in Trials, Stock Up +3.82 (7.32%) @10:12 AM ET

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!Gilead Sciences Inc. (GILD) is moving its experimental drug combination against hepatitis C into a late- stag…

---